XLAB Exascale Labs Holdings Inc.
Fundamentals / CIK 0002109869 / USDExascale Labs Holdings Inc. reported $14.82M in revenue and a net loss of $12.16M for the fiscal year ended June 30, 2026 (up 111.3% year over year), with a 16.3% gross margin and a -32.4% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open XLAB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2026$14.82M +111.3% YoY
-
Operating Income FY 2026-$4.80M -32.4% margin
-
Net Income FY 2026-$12.16M -82.1% net margin
-
Diluted EPS FY 2026-$8,108.26 Split-adjusted
-
Free Cash Flow FY 2026-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$12.83M Total debt: --
Annual revenue and net income
2 fiscal years (2025 to 2026), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Jun 30 | Jun 30 |
|---|---|---|
| Revenue | $14.82M | $7.02M |
| Cost of Revenue | $12.40M | $5.91M |
| Gross Profit | $2.42M | $1.11M |
| Research & Development | $5.49M | $2.80M |
| Selling, General & Admin | $1.73M | $1.35M |
| Total Operating Expenses | $7.22M | $4.15M |
| Operating Income | -$4.80M | -$3.04M |
| EBITDA | -$4.79M | -$3.04M |
| Income Before Tax | -$12.16M | -$7.66M |
| Net Income | -$12.16M | -$7.66M |
| Basic EPS | -$8,108.26 | -$5,106.44 |
| Diluted EPS | -$8,108.26 | -$5,106.44 |
| Basic Shares Outstanding | 1.5K | 1.5K |
| Diluted Shares Outstanding | 1.5K | 1.5K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2025-09-30 |
|---|---|---|
| Revenue | $4.33M | $3.26M |
| Cost of Revenue | $3.75M | $2.71M |
| Gross Profit | $582K | $551K |
| Research & Development | $1.28M | $865K |
| Selling, General & Admin | $840K | $295K |
| Total Operating Expenses | $2.12M | $1.16M |
| Operating Income | -$1.54M | -$609K |
| EBITDA | -$1.54M | -$607K |
| Income Before Tax | -$11.38M | -$1.52M |
| Net Income | -$11.38M | -$1.52M |
| Basic EPS | -$0.21 | -$0.03 |
| Diluted EPS | -$0.21 | -$0.03 |
| Basic Shares Outstanding | 55.3M | 50.0M |
| Diluted Shares Outstanding | 55.3M | 50.0M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Jun 30 | Jun 30 |
|---|---|---|
| Cash & Cash Equivalents | $2.69M | $4.23M |
| Cash & Short-Term Investments | $2.69M | $4.23M |
| Accounts Receivable, Net | $1.15M | $153K |
| Total Current Assets | $6.52M | $7.30M |
| Property, Plant & Equipment, Net | $13K | $20K |
| Total Non-Current Assets | $203K | $20K |
| Total Assets | $6.73M | $7.32M |
| Accounts Payable | $916K | $90K |
| Total Current Liabilities | $31.89M | $20.32M |
| Total Non-Current Liabilities | $0 | $0 |
| Total Liabilities | $31.89M | $20.32M |
| Common Stock | -- | $15 |
| Retained Earnings | -$25.38M | -$13.22M |
| Total Stockholders' Equity | -$25.16M | -$13.00M |
| Total Equity | -$25.16M | -$13.00M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2025-06-30 |
|---|---|---|---|
| Cash & Cash Equivalents | $12.83M | $2.69M | $4.23M |
| Cash & Short-Term Investments | $12.83M | $2.69M | $4.23M |
| Accounts Receivable, Net | $1.58M | $1.15M | $153K |
| Total Current Assets | $17.21M | $6.52M | $7.30M |
| Property, Plant & Equipment, Net | $11K | $13K | $20K |
| Total Non-Current Assets | $11K | $203K | $20K |
| Total Assets | $17.22M | $6.73M | $7.32M |
| Accounts Payable | $2.02M | $916K | $90K |
| Total Current Liabilities | $3.55M | $31.89M | $20.32M |
| Total Non-Current Liabilities | $0 | $0 | $0 |
| Total Liabilities | $3.55M | $31.89M | $20.32M |
| Common Stock | -- | -- | $15 |
| Retained Earnings | -$36.76M | -$25.38M | -$13.22M |
| Total Stockholders' Equity | $13.67M | -$25.16M | -$13.00M |
| Total Equity | $13.67M | -$25.16M | -$13.00M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Jun 30 | Jun 30 |
|---|---|---|
| Net Income | -$12.16M | -$7.66M |
| Depreciation & Amortization | $6.8K | $6.2K |
| Stock-Based Compensation | $0 | $153K |
| Change in Receivables | -$993K | -$29K |
| Change in Payables | $826K | -$38K |
| Operating Cash Flow | -$2.75M | -$1.01M |
| Capital Expenditure | -- | -$2.1K |
| Free Cash Flow | -- | -$1.01M |
| Investing Cash Flow | $1.41M | -$2.1K |
| Financing Cash Flow | -$190K | $4.28M |
| Net Change in Cash | -$1.54M | $3.26M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2025-09-30 |
|---|---|---|
| Net Income | -$11.38M | -$1.52M |
| Depreciation & Amortization | $1.6K | $2.1K |
| Stock-Based Compensation | $0 | $0 |
| Change in Receivables | -$432K | -$687K |
| Change in Payables | $1.11M | $68K |
| Operating Cash Flow | -$648K | -$3.77M |
| Investing Cash Flow | -$550K | -- |
| Financing Cash Flow | $11.34M | -$50K |
| Net Change in Cash | $10.14M | -$3.82M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Jun 30 | Jun 30 |
|---|---|---|
| Gross Margin | 16.3% | 15.8% |
| Operating Margin | -32.4% | -43.4% |
| Net Profit Margin | -82.1% | -109.2% |
| Return on Assets (ROA) | -180.8% | -104.6% |
| Current Ratio | 0.20x | 0.36x |
| Quick Ratio | 0.12x | 0.22x |
| Revenue Growth (YoY) | +111.3% | -- |
| Gross Profit Growth (YoY) | +118.8% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2025-09-30 |
|---|---|---|
| Current Ratio | 4.85x | -- |
| Quick Ratio | 4.06x | -- |
| Revenue Growth (YoY) | +32.8% | -- |
| Gross Profit Growth (YoY) | +5.6% | -- |